Nanomedicine has achieved significant progress in the field of cardiovascular diseases. Nanomaterials can suppress inflammation, promote the repair and regeneration of cardiomyocytes, facilitate vascular remodeling, and enable precise drug delivery. Additionally, nanomaterials can assist imaging techniques, enabling the visualization of the localization, activation, and therapeutic responses of immune cells and stromal cells in vascular diseases. Despite these advances, this field still faces some challenges and limitations. One major concern is the biocompatibility and long-term safety of nanomaterials, which require further investigation and optimization. Furthermore, improvements in the preparation and characterization techniques are also essential to enhance their efficiency and stability. Consequently, more comprehensive research and extensive clinical validation are necessary to ensure the effectiveness and feasibility of nanomedicine applications in cardiovascular disease management.
Among various types of nanomaterials, biological nanomaterials stand out due to their high delivery efficiency and superior biosafety profiles for the diagnosis and treatment of cardiovascular diseases. The versatility of nanomaterials further allows for functions such as targeted therapy, signal transduction, and drug delivery. However, research in cardiovascular medicine is still less developed compared to the advancement made in cancer nanotechnology.
In recent years, nanomaterials have demonstrated unique advantages in cardiovascular interventional therapy. By integrating with interventional techniques, nanomaterials enable more precise targeted treatments, thereby improving therapeutic efficacy and minimizing damage to surrounding tissues. Moreover, nanomaterials can be utilized in interventional therapy for real-time imaging and diagnosis, assisting clinicians in more accurately evaluating pathological conditions and guiding treatment strategies. However, research on the application of biological nanomaterials in interventional therapy remains relatively limited.
This research topic aims to investigate the latest progress in the integration of diagnosis and treatment of cardiovascular diseases using biological nanomaterials, as well as the principles and clinical application background of the advantages of utilizing biological nanomaterials. We warmly welcome the original research findings, insightful perspectives and comprehensive reviews that contribute to the development of nanomedicine for cardiovascular diseases, advance fundamental understanding, and support the continued investigation in this field.
We invite contributions that delve into, but not limited to, the following theme:
• Evaluation of non-invasive diagnosis techniques using biological nanomaterials.
• Analytical results and clinical relevance of non-invasive diagnosis approaches with biological nanomaterials.
• Innovative strategies for cardiovascular disease treatment leveraging biological nanomaterials.
• Assessment of demographic factors, such as gender and racial differences, in the non-invasive diagnosis using biological nanomaterials.
• Evaluation of the therapeutic efficacy of biological nanomaterials for cardiovascular diseases.
• Studies on the prospects and challenges of applying biological nanomaterials in cardiovascular interventional therapy.
• Analysis of market trends regarding the application of biological nanomaterials in cardiovascular interventions.

Are you interested in contributing a manuscript to this Research Topic?

Nanoparticle Medicine Applications in Cardiovascular diseases

Topic Coordinator